Details About Generic Salt ::  Cefaclor

Main Medicine Class::    

(SEFF-uh-klor)

Ceclor, Ceclor CD, Ceclor Pulvules

Class: Antibiotic/cephalosporin

 

Drugs Class ::

 Action Inhibits mucopeptide synthesis in bacterial cell wall.

Indications for Drugs ::

 Indications Treatment of infections of respiratory tract, urinary tract, skin and skin structures; treatment of otitis media due to susceptible strains of specific microorganisms.

Drug Dose ::

 Route/Dosage

ADULTS: PO 250 to 500 mg q 8 hr. Children: PO 20 to 40 mg/kg/day in divided doses q 8 hr (for otitis media and pharyngitis: q 12 hr). (Maximum 1 g/day).

Acute Bacterial Exacerbations of Chronic Bronchitis

ADULTS: Extended release: PO 500 mg/day for 7 days.

Secondary Bacterial Infection of Acute Bronchitis

ADULTS: PO 500 mg/12 hours for 7 days.

Pharyngitis or Tonsillitis

ADULTS: PO 375 mg/12 hours for 10 days.

Uncomplicated Skin and Skin Structure Infections

ADULTS: PO 375 mg/12 hours for 7 to 10 days.

Contraindication ::

 Contraindications Hypersensitivity to cephalosporins.

Drug Precautions ::

 Precautions

Pregnancy: Category B. Lactation: Excreted in breast milk. Children: In infants, consider benefits relative to risks. Safety and efficacy in children < 1 mo not established. Hypersensitivity: Reactions range from mild to life-threatening. Administer drug with caution to penicillin-sensitive patients due to possible cross-reactivity. Pseudomembranous colitis: Should be considered in patients in whom diarrhea develops. Renal impairment: Use drug with caution in patients with renal impairment. Dosage adjustment based on renal function may be required. Superinfection: May result in bacterial or fungal overgrowth of non-susceptible microorganisms.

PATIENT CARE CONSIDERATIONS

Drug Side Effects ::

 Adverse Reactions

GI: Nausea; vomiting; diarrhea; anorexia; abdominal pain or cramps; flatulence; colitis, including pseudomembranous colitis. GU: Pyuria; renal dysfunction; dysuria; reversible interstitial nephritis; hematuria; toxic nephropathy. HEMA: Eosinophilia; neutropenia; lymphocytosis; leukocytosis; thrombocytopenia; decreased platelet function; anemia; aplastic anemia; hemorrhage. HEPA: Hepatic dysfunction, abnormal liver function test results. OTHER: Hypersensitivity, including Stevens-Johnson syndrome, erythema multiforme and toxic epidermal necrolysis; serum sickness–like reactions (eg, skin rash, polyarthritis, arthralgia, fever); candidal overgrowth.

Drug Mode of Action ::  

 Action Inhibits mucopeptide synthesis in bacterial cell wall.

Drug Interactions ::

 Interactions

Probenecid: Inhibition of renal excretion of cefaclor.

Drug Assesment ::

 Assessment/Interventions

• Obtain patient history, including drug history and any known allergies. Note renal impairment and allergy to cephalosporins or penicillins.
• Obtain specimens for culture and sensitivity before beginning therapy and periodically during treatment.
• Monitor renal function carefully during treatment.
• Monitor for signs of infection, especially fever, and for positive response to antibiotic therapy.
• Assess for signs and symptoms of anaphylaxis (shortness of breath, wheezing, laryngeal spasm). Have resuscitation equipment available.
• Assess for symptoms of superinfection, such as vaginitis or stomatitis.
• Assess for severe diarrhea with blood or pus, which may be symptom of pseudomembranous colitis. Symptoms may occur after antibiotic treatment.

OVERDOSAGE: SIGNS & SYMPTOMS   Seizures

Drug Storage/Management ::

 Administration/Storage

• Administer with food or milk if GI upset occurs.
• Tablets, Extended Release: Administer with food to enhance absorption. Do not crush or chew.
• After reconstitution, oral suspension must be refrigerated and will remain stable for up to 14 days. Do not freeze. Shake well before use. Do not administer if solution is cloudy or precipitate is present.

Drug Notes ::

 Patient/Family Education

• Instruct patient to complete full course of therapy.
• Instruct patient to check body temperature daily. If fever persists for more than a few days or if high fever (> 102°F) or shaking chills are noted, physician should be notified immediately.
• Advise patient to maintain normal fluid intake while using this medication.
• Advise diabetic patient to use enzyme-based tests (eg, Clinistix, Testape) for monitoring urine glucose because drug may give false results with other tests.
• Instruct patient to report these symptoms to physician: nausea, vomiting, diarrhea, skin rash, hives, muscle or joint pain.
• Advise patient to report signs of superinfection: Black “furry” tongue, white patches in mouth, foul-smelling stools, vaginal itching or discharge.
• Warn patient that diarrhea that contains blood or pus may be a sign of serious disorders. Tell patient to seek medical care and not to treat at home.
• Instruct patient to seek emergency care immediately if wheezing or difficulty in breathing occurs.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.